VRDN-001, a Full Antagonist Antibody to IGF-1R in Development for Thyroid Eye Disease (TED), Binds to a Distinct Epitope from Teprotumumab
North American Neuro-Ophthalmology Society 2023 Annual Meeting | March 2023
View the full presentation